Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-landos-expand-pipeline-immunity-related-illnesses-2024-03-25/
https://www.globenewswire.com/news-release/2024/03/25/2851619/0/en/AbbVie-to-Acquire-Landos-Biopharma-Further-Strengthening-its-Portfolio-in-Inflammatory-and-Autoimmune-Diseases.html
https://www.globenewswire.com/news-release/2024/03/21/2850157/0/en/Landos-Biopharma-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Results.html
https://www.globenewswire.com//news-release/2024/01/08/2805383/0/en/Landos-Biopharma-to-Present-New-Data-on-Immunometabolism-at-the-19th-Annual-Congress-of-the-European-Crohn-s-and-Colitis-Organisation.html
https://www.globenewswire.com//news-release/2023/11/21/2784002/0/en/Landos-Biopharma-Publishes-Results-of-NX-13-Phase-1b-Study-in-Ulcerative-Colitis-in-Journal-of-Crohn-s-and-Colitis.html
https://www.globenewswire.com//news-release/2023/11/09/2777272/0/en/Landos-Biopharma-Provides-Company-Update-and-Reports-Third-Quarter-2023-Results.html
https://www.globenewswire.com//news-release/2023/10/23/2764658/0/en/Landos-Biopharma-to-Present-at-the-American-College-of-Gastroenterology-2023-Annual-Scientific-Meeting.html
https://www.globenewswire.com//news-release/2023/09/19/2745549/0/en/Landos-Biopharma-to-Present-New-Data-on-NX-13-from-Phase-1b-Trial-in-Ulcerative-Colitis-at-United-European-Gastroenterology-UEG-Week-2023-Congress.html
https://www.globenewswire.com//news-release/2023/09/14/2743191/0/en/Landos-Biopharma-Announces-Strategic-Research-Collaboration-with-KU-Leuven-and-University-Hospitals-Leuven-to-Further-Characterize-the-Effects-of-NX-13-on-Epithelial-Cells.html